If it ain't broke, sell it

What do you get for producing great results in a government-funded research institute? Privatised, says Charles Arthur

It might sound like good news that a British institution 50 per cent funded by the Government has just been declared to be doing some of the best research in biological sciences in the country - better than any university, by the yardstick used.

Yet to some at the Babraham Institute, in Cambridge, the result announced last week was not unalloyed good news. In their battle against further cuts in their government funding, they fear that this news could be just what those pushing for privatisation want.

The findings came in the latest data from the Institute for Scientific Information (ISI), an independent Philadelphia-based organisation which does one core activity: it looks at all the scientific papers published all over the world, and notes which papers they cite, and in turn which future papers cite the original.

This so-called "citation index" has rapidly become the ruler against which any paper is measured, the quickest way to find out which areas of research are buzzing, and which authors and papers within those fields are hottest. Any scientist with even a hint of vanity follows their paper's position in the ISI Index with the breathless enthusiasm of a would-be pop star scanning the charts for signs of their latest single.

Thus Richard Dyer, head of the Babraham Institute, could be forgiven for feeling a warm glow of satisfaction when the latest ISI Index showed that papers in the field of biological sciences published by scientists at the Babraham were more frequently cited than any British university's. In fact, the institute came second only to the well-known Molecular Biology Laboratory, also in Cambridge, which is funded by the Medical Research Council.

The Babraham is slightly different. It specialises in the life sciences, and particularly in the fields of "cell signalling" - the process by which cells communicate chemically - and animal development and the recognition mechanisms at cellular level that are essential for life.

This is done by looking at the "pathways" between cells - usually in pigs and mice. When signalling goes wrong, the effect can be cancerous; so there are implications for human disease and their control. The work ultimately has applications in biotechnology, pharmaceuticals, and biomedicine. But the Institute's work is more in the nature of basic research. The most cited Babraham paper, from Nature in 1984, discussed a cell signal messenger called inositol triphosphate. Against the "expected" 517 citations, it received 5.028. A 1993 Babraham paper on a similar topic received 1,364 citations, rather than the expected 160.

Officially, the 450-strong institute is a registered charity: but it receives underpinning support from the Government via the Biotechnology and Biological Sciences Research Council (BBSRC), which provides 56 per cent of its pounds 15m funding. Other funding comes from private-sector work.

But under the Government's "Prior Options" scheme, any public-sector research establishment is under increasing scrutiny to see whether its work is needed. If it is, the next question is whether the public sector needs to fund that work - that is, should the establishment be privatised. Other options are merger with another organisation or a different mode of management.

The Prior Options system has a Thatcherite ring to it - the option of leaving well alone doesn't seem to be on the list. But that is exactly what Dr Dyer thinks should be done. "We are achieving strong success with our research, we have ambitious plans for the future, and any unnecessary upheaval will be a distraction with the potential to cause much damage to our performance."

The ISI's independent assessment might also seem to imply that the Babraham is doing fine with the system as it is. "We are pleased with the ISI results, but not complacent," says Dr Dyer. There is much more the institute can do, he says - but only if the Government continues its underpinning support.

The trouble is, according to one source at the institute, that the ISI result can be used as fuel by either side - both Dr Dyer's, and the would- be privatisers. Doing well according to ISI's measurement could be taken to mean that the institute has the ideal platform to be launched entirely into the commercial world: by pointing to its past successes, and especially its ISI position, the management could get industrial backing to fund their work.

But what if the ISI citation-meter had shown that the institute was far down the ratings? "They would then say we ought to be privatised because we're not providing value for money," says the source. Dr Dyer comments, "The ISI results show the current arrangements for the institute are a highly effective way to derive excellent value for public money spent on science."

But with Prior Options around, nothing is safe. It may be that the approaching election will simplify matters. The Labour Party, at least, has pledged to stop any privatisation of public research laboratories. Perhaps then the Babraham's staff will be able to breathe a little easier - and get on with their world-beating work.

Arts and Entertainment
Lena Dunham
booksLena Dunham's memoirs - written at the age of 28 - are honest to the point of making you squirm
Arts and Entertainment
A bit rich: Maggie Smith in Downton Abbey
tvDownton Abbey review: It's six months since we last caught up with the Crawley clan
Frank Lampard and his non-celebration
premier leagueManchester City vs Chelsea match report from the Etihad Stadium
Life and Style
A new app has been launched that enables people to have a cuddle from a stranger
techNew app offers 'PG alternative' to dating services like Tinder
Jacqueline Bisset has claimed that young women today are obsessed with being 'hot', rather than 'charming', 'romantic' or 'beautiful'
Arts and Entertainment
Jake Quickenden sings his heart out in his second audition
tvX Factor: How did the Jakes - and Charlie Martinez - fare?
premier league
Arts and Entertainment
'New Tricks' star Dennis Waterman is departing from the show after he completes filming on two more episodes
tvOnly remaining original cast-member to leave crime series
Mario Balotelli celebrates his first Liverpool goal
premier leagueLiverpool striker expressed his opinion about the 5-3 thriller with Leicester - then this happened
ebooksAn unforgettable anthology of contemporary reportage
Britain's shadow chancellor Ed Balls (L) challenges reporter Rob Merrick for the ball during the Labour Party versus the media soccer match,
peopleReporter left bleeding after tackle from shadow Chancellor in annual political football match
Arts and Entertainment
Female fans want more explicit male sex in Game of Thrones, George R R Martin says
tvSpoiler warning: Star of George RR Martin's hit series says viewers have 'not seen the last' of him/her
Plenty to ponder: Amir Khan has had repeated problems with US immigration because of his Muslim faith and now American television may shun him
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Head of Marketing and Communications - London - up to £80,000

£70000 - £80000 per annum: Ashdown Group: Group Head of Marketing and Communic...

Nursery Nurse

Negotiable: Randstad Education Manchester: Level 3 Nursery Nurse required for ...

Nursery Nurse

Negotiable: Randstad Education Manchester: L3 Nursery Nurses urgently required...

SEN Teaching Assistant

Negotiable: Randstad Education Manchester: We have a number of schools based S...

Day In a Page

A roller-coaster tale from the 'voice of a generation'

Not That Kind of Girl:

A roller-coaster tale from 'voice of a generation' Lena Dunham
London is not bedlam or a cradle of vice. In fact it, as much as anywhere, deserves independence

London is not bedlam or a cradle of vice

In fact it, as much as anywhere, deserves independence
Vivienne Westwood 'didn’t want' relationship with Malcolm McLaren

Vivienne Westwood 'didn’t want' relationship with McLaren

Designer 'felt pressured' into going out with Sex Pistols manager
Jourdan Dunn: Model mother

Model mother

Jordan Dunn became one of the best-paid models in the world
Apple still coolest brand – despite U2 PR disaster

Apple still the coolest brand

Despite PR disaster of free U2 album
Scottish referendum: The Yes vote was the love that dared speak its name, but it was not to be

Despite the result, this is the end of the status quo

Boyd Tonkin on the fall-out from the Scottish referendum
Manolo Blahnik: The high priest of heels talks flats, Englishness, and why he loves Mary Beard

Manolo Blahnik: Flats, Englishness, and Mary Beard

The shoe designer who has been dubbed 'the patron saint of the stiletto'
The Beatles biographer reveals exclusive original manuscripts of some of the best pop songs ever written

Scrambled eggs and LSD

Behind The Beatles' lyrics - thanks to Hunter Davis's original manuscript copies
'Normcore' fashion: Blending in is the new standing out in latest catwalk non-trend

'Normcore': Blending in is the new standing out

Just when fashion was in grave danger of running out of trends, it only went and invented the non-trend. Rebecca Gonsalves investigates
Dance’s new leading ladies fight back: How female vocalists are now writing their own hits

New leading ladies of dance fight back

How female vocalists are now writing their own hits
Mystery of the Ground Zero wedding photo

A shot in the dark

Mystery of the wedding photo from Ground Zero
His life, the universe and everything

His life, the universe and everything

New biography sheds light on comic genius of Douglas Adams
Save us from small screen superheroes

Save us from small screen superheroes

Shows like Agents of S.H.I.E.L.D are little more than marketing tools
Reach for the skies

Reach for the skies

From pools to football pitches, rooftop living is looking up
These are the 12 best hotel spas in the UK

12 best hotel spas in the UK

Some hotels go all out on facilities; others stand out for the sheer quality of treatments